A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

The Centers for Disease Control and Prevention has awarded a $1.4 million grant to a University of Albany professor, Melonie ...

Learn about HIV stages, prevention methods and treatment options including modern testing approaches for better health management in 2025.

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

Phoenix is looking for artists to create a mural for a community health center downtown. Applications are being accepted from ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark ... Injectable Cabotegravir for HIV Prevention Is Safe in Pregnancy, Study ...

The company recently released phase 3 data showing that a twice-yearly treatment with lenacapavir was 100% effective in HIV prevention in ... programme focused on HIV/AIDS, said that the treatment ...

December is HIV/AIDS ... White HIV/AIDS Program to provide services for underserved populations with HIV/AIDS. The long-term goal in the U.S. is to end the HIV epidemic through prevention and ...

Health workers and researchers say an HIV outbreak in West Virginia that three years ago was called “the most concerning” in ...

HealthDay News — In a special communication issued by the International Antiviral Society-USA Panel and published online Dec. 1 in the Journal of the American Medical Association, the latest ...